1. Home
  2. RGEN vs VFS Comparison

RGEN vs VFS Comparison

Compare RGEN & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • VFS
  • Stock Information
  • Founded
  • RGEN 1981
  • VFS 2017
  • Country
  • RGEN United States
  • VFS Vietnam
  • Employees
  • RGEN N/A
  • VFS N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • VFS Blank Checks
  • Sector
  • RGEN Health Care
  • VFS Finance
  • Exchange
  • RGEN Nasdaq
  • VFS Nasdaq
  • Market Cap
  • RGEN 7.6B
  • VFS 9.4B
  • IPO Year
  • RGEN N/A
  • VFS N/A
  • Fundamental
  • Price
  • RGEN $156.55
  • VFS $4.18
  • Analyst Decision
  • RGEN Buy
  • VFS Strong Buy
  • Analyst Count
  • RGEN 12
  • VFS 4
  • Target Price
  • RGEN $187.44
  • VFS $9.00
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • VFS 771.0K
  • Earning Date
  • RGEN 02-19-2025
  • VFS 02-20-2025
  • Dividend Yield
  • RGEN N/A
  • VFS N/A
  • EPS Growth
  • RGEN N/A
  • VFS N/A
  • EPS
  • RGEN N/A
  • VFS N/A
  • Revenue
  • RGEN $633,513,000.00
  • VFS $1,517,342,313.00
  • Revenue This Year
  • RGEN $2.28
  • VFS N/A
  • Revenue Next Year
  • RGEN $9.88
  • VFS $51.01
  • P/E Ratio
  • RGEN N/A
  • VFS N/A
  • Revenue Growth
  • RGEN N/A
  • VFS 64.54
  • 52 Week Low
  • RGEN $113.50
  • VFS $2.26
  • 52 Week High
  • RGEN $211.13
  • VFS $6.55
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • VFS 47.85
  • Support Level
  • RGEN $149.15
  • VFS $4.03
  • Resistance Level
  • RGEN $160.64
  • VFS $4.65
  • Average True Range (ATR)
  • RGEN 5.96
  • VFS 0.23
  • MACD
  • RGEN 0.91
  • VFS -0.02
  • Stochastic Oscillator
  • RGEN 79.57
  • VFS 27.78

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Automobiles, E-scooter, Spare parts & Aftermarket services. The Automobiles segment includes the design, development, manufacturing, and sales of cars and electric buses; The E-scooter segment includes the design, development, manufacturing, and sales of e-scooters; the Spare parts & Aftermarket services segment includes the sales of spare parts and rendering of aftermarket services for automobiles and e-scooters.

Share on Social Networks: